Bousquet, J.* ; Schünemann, H.J.* ; Samolinski, B.* ; Demoly, P.* ; Baena-Cagnani, C.E.* ; Bachert, C.* ; Bonini, S.* ; Boulet, L.P.* ; Bousquet, P.J.* ; Brozek, J.L.* ; Canonica, G.W.* ; Casale, T.B.* ; Cruz, A.A.* ; Fokkens, W.J.* ; Fonseca, J.A.* ; van Wijk, R.G.* ; Grouse, L.* ; Haahtela, T.* ; Khaltaev, N.* ; Kuna, P.* ; Lockey, R.F.* ; Carlsen, K.C.L.* ; Mullol, J.* ; Naclerio, R.* ; O'Hehir, R.E.* ; Ohta, K.* ; Palkonen, S.* ; Papadopoulos, N.G.* ; Passalacqua, G.* ; Pawankar, R.* ; Price, D.* ; Ryan, D.* ; Simons, F.E.R.* ; Togias, A.* ; Williams, D.* ; Yorgancioglu, A.* ; Yusuf, O.M.* ; Aberer, W.* ; Adachi, M.* ; Agache, I.* ; Ait-Khaled, N.* ; Akdis, C.A.* ; Andrianarisoa, A.* ; Annesi-Maesano, I.* ; Ansotegui, I.J.* ; Baiardini, I.* ; Bateman, E.D.* ; Bedbrook, A.* ; Beghe, B.* ; Beji, M.* ; Bel, E.H.* ; Ben Kheder, A.* ; Bennoor, K.S.* ; Bergmann, K.C.* ; Berrissoul, F.* ; Bieber, T.* ; Jensen, C.B.* ; Blaiss, M.S.* ; Boner, A.L.* ; Bouchard, J.* ; Braido, F.* ; Brightling, C.E.* ; Bush, A.* ; Caballero, F.* ; Calderon, M.A.* ; Calvo, M.A.* ; Camargos, P.A.M.* ; Caraballo, L.R.* ; Carlsen, K.H.* ; Carr, W.* ; Cepeda, A.M.* ; Cesario, A.* ; Chavannes, N.H.* ; Chen, Y.Z.* ; Chiriac, A.M.* ; Perez, T.C.* ; Chkhartishvili, E.* ; Ciprandi, G.* ; Costa, D.J.* ; Cox, L.* ; Custovic, A.* ; Dahl, R.* ; Darsow, U. ; de Blay, F.* ; Deleanu, D.* ; Denburg, J.A.* ; Devillier, P.* ; Didi, T.* ; Dokic, D.* ; Dolen, W.K.* ; Douagui, H.* ; Dubakiene, R.* ; Durham, S.R.* ; Dykewicz, M.S.* ; El-Gamal, Y.* ; El-Meziane, A.* ; Emuzyte, R.* ; Fiocchi, A.* ; Fletcher, M.* ; Fukuda, T.* ; Gamkrelidze, A.* ; Gereda, J.E.* ; Diaz, S.G.* ; Gotua, M.* ; Guzman, M.A.* ; Hellings, P.W.* ; Hellquist-Dahl, B.* ; Horak, F.* ; Hourihane, J.O.* ; Howarth, P.* ; Humbert, M.* ; Ivancevich, J.C.* ; Jackson, C.* ; Just, J.* ; Kalayci, O.* ; Kaliner, M.A.* ; Kalyoncu, A.F.* ; Keil, T.* ; Keith, P.K.* ; Khayat, G.* ; Kim, Y.Y.* ; N'Goran, B.K.* ; Koppelman, G.H.* ; Kowalski, M.L.* ; Kull, I.* ; Kvedariene, V.* ; Larenas-Linnemann, D.* ; Le, L.T.* ; Lemiere, C.* ; Li, J.* ; Lieberman, P.* ; Lipworth, B.* ; Mahboub, B.* ; Makela, M.J.* ; Martin, F.* ; Marshall, G.D.* ; Martinez, F.D.* ; Masjedi, M.R.* ; Maurer, M.* ; Mavale-Manuel, S.* ; Mazon, A.* ; Melén, E.* ; Meltzer, E.O.* ; Mendez, N.H.* ; Merk, H.* ; Mihaltan, F.* ; Mohammad, Y.* ; Morais-Almeida, M.* ; Muraro, A.* ; Nafti, S.* ; Namazova-Baranova, L.* ; Nekam, K.* ; Neou, A.* ; Niggemann, B.* ; Niżankowska-Mogilnicka, E.* ; Nyembue, T.D.* ; Okamoto, Y.* ; Okubo, K.* ; Orru, M.P.* ; Ouedraogo, S.* ; Ozdemir, C.* ; Panzner, P.* ; Pali-Scholl, I.* ; Park, H.S.* ; Pigearias, B.* ; Pohl, W.* ; Popov, T.A.* ; Postma, D.S.* ; Potter, P.* ; Rabe, K.F.* ; Ratomaharo, J.* ; Reitamo, S.* ; Ring, J.* ; Roberts, R.* ; Rogala, B.* ; Romano, A.* ; Rodriguez, M.R.* ; Rosado-Pinto, J.* ; Rosenwasser, L.* ; Rottem, M.* ; Sanchez-Borges, M.* ; Scadding, G.K.* ; Schmid-Grendelmeier, P.* ; Sheikh, A.* ; Sisul, J.C.* ; Sole, D.* ; Sooronbaev, T.* ; Spicak, V.* ; Spranger, O.* ; Stein, R.T.* ; Stoloff, S.W.* ; Sunyer, J.* ; Szczeklik, A.* ; Todo-Bom, A.* ; Toskala, E.* ; Tremblay, Y.* ; Valenta, R.* ; Valero, A.L.* ; Valeyre, D.* ; Valiulis, A.* ; Valovirta, E.* ; van Cauwenberge, P.* ; Vandenplas, O.* ; van Weel, C.* ; Vichyanond, P.* ; Viegi, G.* ; Wang, D.Y.* ; Wickman, M.* ; Wohrl, S.* ; Wright, J.* ; Yawn, B.P.* ; Yiallouros, P.K.* ; Zar, H.J.* ; Zernotti, M.E.* ; Zhong, N.* ; Zidarn, M.* ; Zuberbier, T.*
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs.
J. Allergy Clin. Immunol. 130, 1049-1062 (2012)
Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified ARas mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIAWorld Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children. (J Allergy Clin Immunol 2012;130:1049-62.)
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Rhinitis ; Asthma ; Allergic Rhinitis And Its Impact On Asthma ; Allergy ; Grade; Quality-of-life ; World-health-organization ; Persistent Types ; Controlled-trial ; European-union ; Primary-care ; 2008 Update ; Guidelines ; Management ; Classification
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2012
Prepublished im Jahr
HGF-Berichtsjahr
2012
ISSN (print) / ISBN
0091-6749
e-ISSN
1097-6825
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 130,
Heft: 5,
Seiten: 1049-1062
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
Amsterdam [u.a.]
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
80000 - German Center for Lung Research
Forschungsfeld(er)
Allergy
PSP-Element(e)
G-501800-541
Förderungen
Copyright
Erfassungsdatum
2012-12-06